pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-125b-2 |
Genomic Coordinates | chr21: 16590237 - 16590325 |
Synonyms | MIRN125B2, MIR125B2 |
Description | Homo sapiens miR-125b-2 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-125b-2-3p | ||||||||||||||
Sequence | 54| UCACAAGUCAGGCUCUUGGGAC |75 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Cloned | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRAM1 | ||||||||||||||||||||
Synonyms | PNAS8, TRAM, TRAMP | ||||||||||||||||||||
Description | translocation associated membrane protein 1 | ||||||||||||||||||||
Transcript | NM_014294 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRAM1 | |||||||||||||||||||||
3'UTR of TRAM1 (miRNA target sites are highlighted) |
>TRAM1|NM_014294|3'UTR 1 TGAATTATAAACTAATTGATTAATGTCCCCAAAGAAATCTGCTTTCTACTATATCTTTCAGCATTAGAGATTTTTCTGTT 81 CTTGAAAATACAGTCTGTGCTCTTTGATTTTTGCTATTGTACGGTTTCATGCATTTTTTTAAAGGGCATTTGAGGGGAGG 161 ATTATTGCTATGAATGAAAAAAATATTTTAGCTTAGACTAAGCTACCTGCCTTCAAAATAGTTTAGGGACCACCACCATA 241 TTTTATTTTGTTTTTATTTTTGAACATTTTTCTAATGATTTGGAGAGAAAACTATTTACAAAAATTCCACATATCAGTGA 321 TACAATTTCTTGCTGTCACCAATTTTTTATAATAGCAGAGTGGCCTGTTCTAAGAAGGCCATATTTTTTAAGTTATCTTT 401 CAGGGTAACATGGAAATACTATAAAGTTGGATGTCAAACTTTAATATGTTTTCAGTGTTCTCTAATTTTTTGGAATTTTT 481 GTAGACTTTACACCTGGAAAAAAAGATTTGTAAAATCACCGGAACAATTGTGTGCTTTATTTTATAGGTAGTGGTTATTA 561 GTATTACATCCCCATTTTAAAAACAAAAACATAATAATCGTTACAACACGTGGAGTTTTACTAACATACATATTAAATCA 641 AAGTATATTCTTAAAAGTACTTGTGAAGTAAAATCTTTCTTGTGCATTTTCAATACTTGTAAACTGGAAATCAGAAAATA 721 TTTACTATGAACAGGAAAATCTGACATATAGCCCTTTTTGATATGTTTATTAATAATGATTCTTAATGGGGCTCATAATA 801 AGTTTAATATGCACAGCATCTTAGAAAAGTTTAACCTGCAAACACTTTTAAAACATAATGCCTACTTGATTTATATCTAT 881 AAAAAGACTGACAGGTAATTATATTTGGAAAACATTTAATGCACTAACTTTAAAGAAATTGAAAATTCAGGTGGATAAAT 961 AGTCTTACAAAAGACAATGTGCTTTATGTTATACCTATAGCTTTGGTCCCATCTTTAATTGAGAAACATTTATCTGTATA 1041 AAACATATTTTTGGATAAATATATATATATATATTTGTATCTCTACAGAAAGGCTCTAAAAAGCATTTGAGGAAAATATT 1121 TGGTTCCCTTTTCTATAATCATCCTTTAAGATTCTTATAGCTACATTTGGTTTATTCATCATATTTACAGTATATATATT 1201 GTTCTTTTCAGTGTTCACATCTTGTTCCCCATTTCTCACTTGTGTCACCAGCTGTTTGTGCCATTTTTAGTGTAAAAGTT 1281 GCAGACCTATTAGATCTGCAGTTTAAGTTGCCATGCTGCTAGGAAATTGTCCTTTTTCTTTCTAGCTGTTAACCTACTTC 1361 CTGGAAAAAGTAGTAGCTCTCTGTAGCATTATGGAGTTTCAGTGGAACCAAATTTTTGCCATTAAAAACTGGCATTATAC 1441 TGAACTATACATTGAGAAATCAATCAAAATAAAAATTTTTACTTTCACAAGTTGTATCCTGGATGTTTCTGTCATTGTTG 1521 GTGTTTAGGCTATTTTGGTATATAACCTCATTAAAATGTACCATATTTAAAACACTTCATAGACATTCAGAATAACCCTT 1601 TTCAAAATTGTGTTCTGCAAATAAACAGATTTGTTCCACAGAATATTGGTGAGGACTACTGGGGGGATAGATGGTCATAA 1681 CCAAATAAATCTGGGAATCACTGGATTAAACTAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000521425.1 | 3UTR | UUCACAUCUUGUUCCCCAUUUCUCACUUGUGUCACCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
91 hsa-miR-125b-2-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038624 | HN1L | Jupiter microtubule associated homolog 2 | 1 | 1 | ||||||||
MIRT038625 | KDELC2 | KDEL motif containing 2 | 1 | 1 | ||||||||
MIRT038626 | ABHD15 | abhydrolase domain containing 15 | 1 | 1 | ||||||||
MIRT038627 | PPP1R12C | protein phosphatase 1 regulatory subunit 12C | 1 | 1 | ||||||||
MIRT038628 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 1 | 1 | ||||||||
MIRT038629 | ASH2L | ASH2 like histone lysine methyltransferase complex subunit | 1 | 1 | ||||||||
MIRT038630 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT038631 | CSTB | cystatin B | 1 | 1 | ||||||||
MIRT038632 | SYT2 | synaptotagmin 2 | 1 | 1 | ||||||||
MIRT038633 | NDUFS7 | NADH:ubiquinone oxidoreductase core subunit S7 | 1 | 1 | ||||||||
MIRT038634 | MTA2 | metastasis associated 1 family member 2 | 1 | 1 | ||||||||
MIRT053086 | IGF1R | insulin like growth factor 1 receptor | 3 | 1 | ||||||||
MIRT055788 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 12 | ||||||||
MIRT061248 | AMOTL1 | angiomotin like 1 | 2 | 10 | ||||||||
MIRT061649 | BTG2 | BTG anti-proliferation factor 2 | 2 | 6 | ||||||||
MIRT079046 | TNRC6C | trinucleotide repeat containing 6C | 2 | 4 | ||||||||
MIRT084583 | BCL2L11 | BCL2 like 11 | 2 | 8 | ||||||||
MIRT093523 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 2 | ||||||||
MIRT097383 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 4 | ||||||||
MIRT098030 | SOBP | sine oculis binding protein homolog | 2 | 2 | ||||||||
MIRT186262 | TCEB3 | elongin A | 2 | 2 | ||||||||
MIRT187284 | DAZAP2 | DAZ associated protein 2 | 2 | 10 | ||||||||
MIRT361113 | LRRC1 | leucine rich repeat containing 1 | 2 | 2 | ||||||||
MIRT443585 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT452249 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT476289 | GMFB | glia maturation factor beta | 2 | 8 | ||||||||
MIRT483871 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT484250 | ANK1 | ankyrin 1 | 2 | 2 | ||||||||
MIRT499251 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT502270 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 4 | ||||||||
MIRT504652 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT505210 | UBN2 | ubinuclein 2 | 2 | 6 | ||||||||
MIRT512690 | POP1 | POP1 homolog, ribonuclease P/MRP subunit | 2 | 2 | ||||||||
MIRT517341 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT518946 | LSG1 | large 60S subunit nuclear export GTPase 1 | 2 | 2 | ||||||||
MIRT520866 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 2 | ||||||||
MIRT521236 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT528324 | GIGYF2 | GRB10 interacting GYF protein 2 | 2 | 2 | ||||||||
MIRT533297 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT541024 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT544034 | ERRFI1 | ERBB receptor feedback inhibitor 1 | 2 | 2 | ||||||||
MIRT547037 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT556102 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT558320 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT558520 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT566230 | PTMA | prothymosin, alpha | 2 | 4 | ||||||||
MIRT568437 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT570584 | OTUD7B | OTU deubiquitinase 7B | 2 | 2 | ||||||||
MIRT571384 | JKAMP | JNK1/MAPK8-associated membrane protein | 2 | 2 | ||||||||
MIRT572798 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT573864 | C9orf78 | chromosome 9 open reading frame 78 | 2 | 2 | ||||||||
MIRT609930 | SLC38A1 | solute carrier family 38 member 1 | 2 | 4 | ||||||||
MIRT610437 | CSMD2 | CUB and Sushi multiple domains 2 | 2 | 2 | ||||||||
MIRT614407 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT618625 | GREB1 | growth regulation by estrogen in breast cancer 1 | 2 | 2 | ||||||||
MIRT620605 | SAP30 | Sin3A associated protein 30 | 2 | 2 | ||||||||
MIRT635313 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT635918 | GLTSCR2 | NOP53 ribosome biogenesis factor | 2 | 2 | ||||||||
MIRT638507 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT640597 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT644066 | IQCE | IQ motif containing E | 2 | 2 | ||||||||
MIRT648287 | TRAPPC2L | trafficking protein particle complex 2 like | 2 | 2 | ||||||||
MIRT653089 | SSR3 | signal sequence receptor subunit 3 | 2 | 2 | ||||||||
MIRT654651 | PTAFR | platelet activating factor receptor | 2 | 2 | ||||||||
MIRT658084 | FOXR2 | forkhead box R2 | 2 | 2 | ||||||||
MIRT665306 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT665974 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT674905 | RASSF9 | Ras association domain family member 9 | 2 | 2 | ||||||||
MIRT680085 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT681487 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT691243 | DFNB59 | pejvakin | 2 | 2 | ||||||||
MIRT692361 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT693034 | MB21D1 | Mab-21 domain containing 1 | 2 | 2 | ||||||||
MIRT694478 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT696069 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT696579 | TTC21B | tetratricopeptide repeat domain 21B | 2 | 2 | ||||||||
MIRT696759 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 2 | ||||||||
MIRT697306 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT698736 | STX12 | syntaxin 12 | 2 | 2 | ||||||||
MIRT701055 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT701197 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT701334 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT703617 | FBXO45 | F-box protein 45 | 2 | 2 | ||||||||
MIRT708893 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT711621 | DGKH | diacylglycerol kinase eta | 2 | 2 | ||||||||
MIRT713744 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT715060 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT719711 | CD101 | CD101 molecule | 2 | 2 | ||||||||
MIRT720293 | DLGAP3 | DLG associated protein 3 | 2 | 2 | ||||||||
MIRT722605 | CCDC152 | coiled-coil domain containing 152 | 2 | 2 | ||||||||
MIRT724565 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|